Sandbox reserved 915: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
This Cysteine is buried in the active site near the catalytic serine and functions by sterically clashing with the natural ligand. A possible conformational change to Cys252 upon the binding of NAM could also lead to an inactive form of MGL. | This Cysteine is buried in the active site near the catalytic serine and functions by sterically clashing with the natural ligand. A possible conformational change to Cys252 upon the binding of NAM could also lead to an inactive form of MGL. | ||
MGL is also inhibited by being in complex with <scene name='58/580298/Sar629/2'>SAR629</scene> that is covalently bound to the catalytic Ser132. SAR629 adopts a Y shape and interacts with the MGL by hydrophobic interactions, with a few polar interactions as well. [[Image:SAR.png | MGL is also inhibited by being in complex with <scene name='58/580298/Sar629/2'>SAR629</scene> that is covalently bound to the catalytic Ser132. SAR629 adopts a Y shape and interacts with the MGL by hydrophobic interactions, with a few polar interactions as well. [[Image:SAR.png|'''Figure 3:''' The structure and shape of SAR629.]] | ||
With SAR629 interacting with the catalytic triad it inhibits the triad from breaking down 2-AG and inactivates MGL <ref name="Bertrand" /> | With SAR629 interacting with the catalytic triad it inhibits the triad from breaking down 2-AG and inactivates MGL <ref name="Bertrand" /> | ||